Share this postStock Region ResearchBioscience Company Presents Preclinical Discovery For Obesity TreatmentCopy linkFacebookEmailNotesMoreBioscience Company Presents Preclinical Discovery For Obesity TreatmentElevai Biosciences is gearing up for a significant stride forward with plans to submit an Investigational New Drug (IND) application in 2025.Stock RegionMay 02, 2024∙ PaidShare this postStock Region ResearchBioscience Company Presents Preclinical Discovery For Obesity TreatmentCopy linkFacebookEmailNotesMoreShareCreated with TradingViewGet 20% off a group subscriptionThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext
